Conference call begins at 4:30 p.m. Eastern time today MIAMI, Feb. 27, 2025 (GLOBE...
Results
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...
February 12, 2025 6:54 PM EST | Source: InMed Pharmaceuticals Vancouver, British Columbia--(Newsfile Corp. - February 12, 2025) -...
CAMBRIDGE, Mass., Dec. 18, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel...
Calgary, Alberta--(Newsfile Corp. - November 28, 2024) - Eguana Technologies Inc. (TSXV: EGT) ("Eguana" or the "Company"), a leading provider...
JERUSALEM, Nov. 22, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing...
